These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21146170)

  • 1. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
    Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
    Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
    Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
    Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.
    Zhang X; Bai Q; Kakiyama G; Xu L; Kim JK; Pandak WM; Ren S
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):262-70. PubMed ID: 22732306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
    Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.
    Ren S; Ning Y
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E123-30. PubMed ID: 24302009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate.
    Xu L; Bai Q; Rodriguez-Agudo D; Hylemon PB; Heuman DM; Pandak WM; Ren S
    Lipids; 2010 Sep; 45(9):821-32. PubMed ID: 20700770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes.
    Li X; Pandak WM; Erickson SK; Ma Y; Yin L; Hylemon P; Ren S
    J Lipid Res; 2007 Dec; 48(12):2587-96. PubMed ID: 17890683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes.
    Kase ET; Andersen B; Nebb HI; Rustan AC; Thoresen GH
    Biochim Biophys Acta; 2006 Dec; 1761(12):1515-22. PubMed ID: 17055780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F; Craddock L; Yang J
    Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.
    Cook IT; Duniec-Dmuchowski Z; Kocarek TA; Runge-Morris M; Falany CN
    Drug Metab Dispos; 2009 Oct; 37(10):2069-78. PubMed ID: 19589875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.
    Chen W; Chen G; Head DL; Mangelsdorf DJ; Russell DW
    Cell Metab; 2007 Jan; 5(1):73-9. PubMed ID: 17189208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol.
    Liu Y; Wei Z; Zhang Y; Ma X; Chen Y; Yu M; Ma C; Li X; Cao Y; Liu J; Han J; Yang X; Duan Y
    J Lipid Res; 2018 Dec; 59(12):2287-2296. PubMed ID: 30309895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
    Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
    Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
    Taylor JM; Borthwick F; Bartholomew C; Graham A
    Cardiovasc Res; 2010 Jun; 86(3):526-34. PubMed ID: 20083572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.
    Jiang YJ; Kim P; Elias PM; Feingold KR
    J Lipid Res; 2005 Dec; 46(12):2657-66. PubMed ID: 16150827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.